Showing posts with label Photopheresis Products Market. Show all posts
Showing posts with label Photopheresis Products Market. Show all posts

Monday, November 4, 2019

Photopheresis Products Market (5.5% CAGR) 2017-2025: Global Business Growth, Size and Forecast

The latest market report published by Credence Research, Inc., the global market for photopheresis Products was valued at US$ 257 million in 2017 and is expected to reach US$ 418.56 million by 2026, expanding to CAGR by 5.5 per cent from 2018 to 2026.
Market Insights
Photopheresis uses apheresis and photodynamic therapy to treat blood with a photosensitizing agent followed by treatment with specified wavelengths of light. In photopheresis, buffy coat (WBC and platelets) is separated from the whole blood and then chemically treated with8-methoxypsoralene and exposed to ultraviolet-A light. As the prevalence of autoimmune diseases, ongoing research and development activities are being undertaken to develop the most appropriate treatments. Photopheresis is also seen as a promising treatment for transplant rejection, graft versus host disease, cutaneous T-cell lymphoma, and autoimmune diseases.
Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/photopheresis-market
Based on product types, the global market for photopheresis products is segmented into closed systems and open systems. In 2017, the closed systems segment held the largest market share due to its advanced technology and the increasing preference of patients and physicians for the use of closed systems for photopheresis treatment. The popularity of closed systems is also attributed to their flexible use in all the therapeutic areas considered.
Among the considered therapeutic areas namely, autoimmune diseases, graft versus host disease, cutaneous T-cell lymphoma and solid organ transplant rejection, photopheresis finds highest application in autoimmune diseases. Graft versus host disease is observed as the largest segment in 2017 due to factors such as growing allogeneic transplantations, large number of chronic graft versus host disease patients, evolution of diagnostic technologies and consistently growing efforts in research and development activities.
Geographically, North America is the largest regional market for photopheresis. Presence of large pool of autoimmune disease patients, greater awareness in general population, well-structured reimbursement scenario and widespread presence of market incumbents contribute to the dominant position of North America. On the other hand, Asia Pacific is estimated to be the fastest progressing market for photopheresis. Rapidly developing healthcare infrastructure, significantly large patient pool and improving diagnostics front are the key growth drivers of Asia Pacific market.
The global photopheresis market is highly competitive and diversified, characterized by the presence of large number of players. The domination of the key players is subject to their product diversity and core competencies. Some of the major players operating in the global photopheresis market are Terumo Corporation, Malinckrodt Pharmaceuticals, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, and others.
Key Market Movements:
  • High prevalence of autoimmune diseases, and growing number of transplants, supported by evolved diagnostics technologies
  • Increasing awareness about benefits of apheresis and photopheresis
  • Improving reimbursement for autoimmune diseases and organ transplantations
  • Evolving medical tourism industry in Asia Pacific and Latin America
You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58735
Table of Content
Chapter 1 Preface
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Approach Adopted
1.3.4 Top-Down Approach
1.3.5 Bottom-Up Approach
1.3.6 Phase III – Expert Panel Review
1.3.7 Assumptions
1.4 Market Segmentation
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Photopheresis Products Market
2.1.1 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
2.1.2 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
2.1.3 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)
Chapter 3 Photopheresis Products: Market Dynamics and Outlook
3.1 Introduction
3.2 Market Drivers
3.2.1 XXXX XXXX XXXX XXXX XXXX
3.2.1 Driver 2
3.3 Challenges
3.3.1 Challenge 1
3.3.2 Challenge 2
3.4 Opportunities
3.4.1 Opportunity 1
3.5 Attractive Investment Proposition, by Geography, 2017
3.6 Competitive Landscape, by Key Players, 2017
Chapter 4 Global Photopheresis Products Market, by Type
4.1 Overview
4.2 Closed System
4.3 Open System
Chapter 5 Global Photopheresis Products Market, by Therapeutic Area
5.1 Overview
5.2 Cutaneous T-cell Lymphoma
5.3 Solid Organ Transplant Rejections
5.4 Autoimmune Diseases
5.5 Graft Versus Host Diseases
Chapter 6 Global Photopheresis Products Market, by Geography
……………….
You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58735
About Credence Research (Original Publisher)
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290

Sunday, September 22, 2019

Photopheresis Products Market: Global Industry Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Photopheresis Products Market By Type (Closed System, Open System), By Therapeutic Area (Cutaneous T-Cell Lymphoma, Solid Organ Transplant Rejections, Autoimmune Diseases, Graft Versus Host Diseases) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” The global market for photopheresis Products was valued at US$ 257 million in 2017 and is expected to reach US$ 418.56 million by 2026, increasing to CAGR by 5.5 per cent from 2018 to 2026.

Market Insights

Photopheresis uses apheresis and photodynamic therapy to treat blood with a photosensitizing agent followed by treatment with defined wavelengths of light. In photopheresis, buffy coat (WBC and platelets) is separated from the whole blood and then chemically handled with8-methoxypsoralene and subjected to ultraviolet-A light. As the incidence of autoimmune diseases, ongoing research and development activities are being conducted to develop the most suitable treatments. Photopheresis is also seen as a promising therapy for transplant rejection, graft versus host disease, cutaneous T-cell lymphoma, and autoimmune illnesses.


Based on product kinds, the worldwide market for photopheresis products is segmented into closed systems and open systems. In 2017, the closed systems segment retained the biggest market share owing to its advanced technology and the increasing preference of patients and physicians for the use of closed systems for photopheresis treatment. The popularity of closed systems is also ascribed to their flexible use in all the therapeutic fields considered.

Among the therapeutic fields considered, i.e. autoimmune illnesses, graft versus host illness, cutaneous T-cell lymphoma and strong organ transplant rejection, photopheresis has the greatest application in autoimmune diseases. Graft versus host disease was identified as the biggest segment in 2017 owing to variables such as increasing allogeneic transplantation, a big number of chronic graft versus host disease patients, the evolution of diagnostic techniques and a consistent increase in research and development attempts.

Geographically, North America is the largest regional market for photopheresis. Presence of large pool of autoimmune disease patients, greater awareness in general population, well-structured reimbursement scenario and widespread presence of market incumbents contribute to the dominant position of North America. On the other hand, Asia Pacific is estimated to be the fastest progressing market for photopheresis. Rapidly developing healthcare infrastructure, significantly large patient pool and improving diagnostics front are the key growth drivers of Asia Pacific market.


The global photopheresis market is highly competitive and diversified, characterized by the presence of large number of players. The domination of the key players is subject to their product diversity and core competencies. Some of the major players operating in the global photopheresis market are Terumo Corporation, Malinckrodt Pharmaceuticals, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, and others.

Key Market Movements:

  • High prevalence of autoimmune diseases, and growing number of transplants, supported by evolved diagnostics technologies
  • Increasing awareness about benefits of apheresis and photopheresis
  • Improving reimbursement for autoimmune diseases and organ transplantations
  • Evolving medical tourism industry in Asia Pacific and Latin America
By Type (2016–2026; US$ Mn)
  • Closed System
  • Open System
By Therapeutic Area (2016–2026; US$ Mn)
  • Cutaneous T-cell Lymphoma
  • Solid Organ Transplant Rejections
  • Autoimmune Diseases
  • Graft Versus Host Diseases
By Geography Segment
  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Latin America
Do Inquiry before buying report at https://www.credenceresearch.com/inquiry-before-buying/58735

Monday, December 17, 2018

Photopheresis Products Market Size, Share, Growth, Trends, and Opportunities and Forecast 2018-2026

The latest market report published by Credence Research, Inc. “Photopheresis Products Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global photopheresis market was valued at US$ 257 Mn in 2017 and expected to reach US$ 418.56 Mn by 2026, expanding at a CAGR of 5.5% from 2018 to 2026.
The report titled “Global Photopheresis Products Market: 2018 Edition” examines the potential possibilities and significant trends in the Photopheresis Products industry. The report provides a detailed analysis of the global Photopheresis Products Market including the regional markets of North America, Europe, and the Asia Pacific. It focuses on the Photopheresis Products Markets of the U.S., Canada, UK, India, and Australia. The report also assesses the commercial and residential service sector in the Photopheresis Products industry.
Browse Full Report With Toc: https://www.credenceresearch.com/report/photopheresis-market
Further, Porter’s Five Forces Analysis has been done for the global Photopheresis Products industry. In-depth analysis of key market growth drivers and challenges and the major observable trends in the global Photopheresis Products Market are also given in the report. The growth of the market has been projected taking into consideration various aspects like previous growth patterns, the current trends, the growth drivers, challenges and environmental conditions.
Region/Country Coverage
  • North America- United States & Canada
  • Europe- United Kingdom
  • APAC- India & Australia
Get here the sample in PDF: https://www.credenceresearch.com/sample-request/58735
Company Coverage:
Asahi Spectra USA, Inc., Avantes BV, Cogentix Medical, Inc. (LABORIE Medical Technologies), Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Ocean Optics, Inc., Olympus Medical Systems (Olympus Corporation), SOPRO-COMEG GmbH, Smith & Nephew Plc, Stryker Corporation, and Excelitas Technologies Corp.
Executive summary: 
Photopheresis employs apheresis and photodynamic therapy for treating blood with photosensitizing agent followed by treatment with specified wavelengths of light. In photopheresis, buffy coat (WBC and platelets) is separated from the whole blood and thereafter chemically treated with 8-methoxypsoralen and exposed to ultraviolet-A light. As the prevalence of autoimmune diseases, perpetual research and development activities are being undertaken to devise the most appropriate treatments. Photopheresis is also touted as a promising treatment for treatment of transplant rejection, graft versus host disease, cutaneous T-cell lymphoma and autoimmune diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global Photopheresis Products Market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global Photopheresis Products Market
- Leading company profiles reveal details of key Photopheresis Products Market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global Photopheresis Products Market with 7-year forecasts
Reasons to buy
- What was the size of the global Photopheresis Products Market by value in 2017?
- What will be the size of the global Photopheresis Products Market in 2026?
- What factors are affecting the strength of competition in the global Photopheresis Products Market?
- How has the market performed over the last five years?
- What are the main segments that make up the global Photopheresis Products Market?
Request Customization: https://www.credenceresearch.com/request-for-customization/58735
Our Blog: http://www.technicaltop.com/
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
Follow Us: Twitter
LinkedIn @ https://us.linkedin.com/company/credenceresearch

Bone Cement Market | Major players are Zimmer Biomet, Stryker Corporation, DePuy Synthes, Cook Medical, DePuy Synthes, Smith & Nephew

The latest market report published by Credence Research, Inc. “ Bone Cement Market  –  Growth, Future Prospects, and Competitive Analysis,...